Réanimation et soins intensifs du patient en Insuffisance respiratoire aigüe (GRC RESPIRE)

• Article dans une revue

Adaptation of French general practitioners for the management of nursing home patients during COVID-19 in 2020: a multilevel analysis

Véronique Orcel, Tiphanie Bouchez, Aline Ramond-Roquin, Yann Bourgueil, Vincent Renard, Sylvain Gautier, Julien Le Breton

Background: To describe French general practioners' (GPs) adaptation strategies to ensure follow-up care of nursing home patients during the first wave of COVID-19 (May 2020) and to identify factors associated with each strategy. Methods: A national cross-sectional study was conducted with…

BMC Primary Care, 2024, 25 (1), pp.350. ⟨10.1186/s12875-024-02560-9⟩. ⟨hal-04718281⟩

• Article dans une revue

CAR T‐cell therapy induces a high rate of prolonged remission in relapsed primary CNS lymphoma: Real‐life results of the LOC network

Sylvain Choquet, Carole Soussain, Nabih Azar, Véronique Morel, Carole Metz, Renata Ursu, Agathe Waultier-Rascalou, Roberta Di Blasi, Roch Houot, Laëtitia Souchet, Damien Roos-Weil, Madalina Uzunov, Stephanie Nguyen-Quoc, Nathalie Jacque, Inès Boussen, Nicolas Gauthier, Maya Ouzegdouh, Marie Blonski, Arnaud Campidelli, Guido Ahle, Blandine Guffroy, Lise Willems, Emilie Corvilain, Maryline Barrie, Marion Alcantara, Magali Le Garff-Tavernier, Dimitri Psimaras, Nicolas Weiss, Marine Baron, Clotilde Bravetti, Khe Hoang-Xuan, Frederic Davi, Natalia Shor, Agusti Alentorn, Caroline Houillier

The prognosis of relapsed primary central nervous system lymphoma (PCNSL) remains dismal. CAR T‐cells are a major contributor to systemic lymphomas, but their use in PCNSL is limited. From the LOC network database, we retrospectively selected PCNSL who had leukapheresis for CAR‐T cells from the…

American Journal of Hematology, 2024, 99 (7), pp.1240-1249. ⟨10.1002/ajh.27316⟩. ⟨hal-04574661⟩

• Article dans une revue

Treatment of COVID-19-associated ARDS with umbilical cord-derived mesenchymal stromal cells in the STROMA-CoV-2 multicenter randomized double-blind trial: long-term safety, respiratory function, and quality of life

Alexandre Sitbon, Caroline Hauw-Berlemont, Miryam Mebarki, Nicholas Heming, Julien Mayaux, Jean-Luc Diehl, Alexandre Demoule, Djillali Annane, Clémence Marois, Sophie Demeret, Emmanuel Weiss, Guillaume Voiriot, Muriel Fartoukh, Jean‐michel Constantin, Bruno Mégarbane, Gaëtan Plantefève, Hélène Boucher-Pillet, Guillaume Churlaud, Audrey Cras, Camille Maheux, Chloé Pezzana, Mamadou Hassimiou Diallo, Said Lebbah, Jacques Ropers, Joe-Elie Salem, Christian Straus, Philippe Menasché, Jérôme Larghero, Antoine Monsel

Background: The STROMA-CoV-2 study was a French phase 2b, multicenter, double-blind, randomized, placebo-controlled clinical trial that did not identify a significant efficacy of umbilical cord-derived mesenchymal stromal cells in patients with SARS-CoV-2-induced acute respiratory distress syndrome…

Current Stem Cell Research & Therapy, 2024, 15 (1), pp.109. ⟨10.1186/s13287-024-03729-w⟩. ⟨hal-04573073⟩

• Article dans une revue

A “Feed”-Back on EEG Monitoring Artifacts

Julie Lévi-Strauss, Virginie Lambrecq, Nicolas Weiss, Lucas Di Meglio

Neurocritical Care, 2024, ⟨10.1007/s12028-023-01936-6⟩. ⟨hal-04473371⟩